logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
J

Jeffrey A. Cohen

mellen center for ms treatment and research
H指数:82
被引数:3.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Disease-modifying treatment preferences and decision-making in a multiple sclerosis randomized and observational clinical trial (DELIVER-MS)

多发性硬化随机和观察性临床试验（DELIVER-MS）中的疾病修饰治疗偏好与决策制定

Multiple Sclerosis Journal
IF5
2026-05-310
PRE
Emma C Tallantyre; Sarah M Planchon; Harriet Howard; John Mays; Nadia Frowd; Jeffrey A Cohen; Alasdair Coles; Carrie M Hersh; Deborah M Miller; Meredith Dever; Emma H Gray; Nicholas G LaRocca; Kunio Nakamura; Clare Bale; Gwen Covey-Crump; Enrique Alvarez; Tarunya Arun; Wallace J Brownlee; Matt Craner; Leorah Freeman; Natasha Frost; Myla D Goldman; Rajesh K Gupta; Katharine E Harding; Jeremy Hobart; George J Hutton; Megan H Hyland; Seema Kalra; Meena Kannan; Orhun Kantarci; Daniel Lashley; Oliver Lily; Don Mahad; Jacqueline A Nicholas; Richard Nicholas; David Paling; Owen R Pearson; Claire M Rice; Rohini Samudralwar; William F Schmalstieg; Mini Singh; Ei Zune The; Bianca Weinstock-Guttman; Aram Zabeti; Thomas E Love; Douglas D Gunzler; Yi Liu; Stephen Gerry; Nikos Evangelou; Daniel Ontaneda
GA Depot, a long-acting glatiramer acetate, vs placebo in patients with relapsing multiple sclerosis: A randomized phase 3 clinical trial

GA Depot（一种长效醋酸格拉替雷）与安慰剂在复发型多发性硬化患者中的比较：一项随机III期临床试验

Multiple Sclerosis Journal
IF5
2026-02-180
PRE
Aaron Miller; Jeffrey A Cohen; Arnon Karni; Laura Popper; Nadav Bleich Kimelman; Shai Rubnov; Uri Danon; Ehud Marom; Alexey Boyko; Robert Zivadinov; Joseph R Berger; Amit Bar-Or; Hadar Kolb
Prospective SARS-CoV-2 additional vaccination in immunosuppressanttreated individuals with autoimmune diseases in a randomized controlled trial

在随机对照试验中，免疫抑制治疗的自身免疫性疾病患者中SARS-CoV-2加强疫苗接种的前瞻性研究

JCI Insight
IF6.1
2026-01-090
OA
Mackay, Meggan; Wagner, Catriona A.; Pinckney, Ashley; Cohen, Jeffrey A.; Wallace, Zachary S.; Khosroshahi, Arezou; Sparks, Jeffrey A.; Lord, Sandra; Saxena, Amit; Caricchio, Roberto; Kim, Alfred H. J.; Kamen, Diane L.; Koumpouras, Fotios; Askanase, Anca D.; Smith, Kenneth; Guthridge, Joel M.; Pardo, Gabriel; Mao-Draayer, Yang; Macwana, Susan; McCarthy, Sean; Sherman, Matthew A.; Hamrah, Sanaz Daneshfar; Veri, Maria; Walker, Sarah; York, Kate; Tedeschi, Sara K.; Wang, Jennifer; Dziubla, Gabrielle; Castro, Mike; Carroll, Robin; Narpala, Sandeep; Lin, Bob C.; Serebryannyy, Leonid; McDermott, Adrian B.; Barry, William T.; Goldmuntz, Ellen; McNamara, James; Payne, Aimee S.; Bar-Or, Amit; Khanna, Dinesh; James, Judith A.
Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Final analysis of the DAYBREAK open-label extension trial

奥扎尼妥（ozanimod）在复发型多发性硬化中的长期安全性与有效性：DAYBREAK开放标签扩展试验的最终分析

Multiple Sclerosis Journal
IF5
2025-11-050
OA
Krzysztof W Selmaj; Lawrence Steinman; Giancarlo Comi; Amit Bar-Or; Douglas L Arnold; Hans-Peter Hartung; Xavier Montalbán; Eva K Havrdová; James K Sheffield; Anthony Krakovich; Chun-Yen Cheng; Jon V Riolo; Chahin Pachai; Andrew Thorpe; Erik DeBoer; Ludwig Kappos; Jeffrey A Cohen; Bruce AC Cree
Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria

多发性硬化症的诊断：2024年麦卡唐纳标准的修订

lancet neurology
IF0
2025-09-170
OA
Xavier Montalban; Christine Lebrun-Frénay; Jiwon Oh; Georgina Arrambide; Marcello Moccia; Maria Pia Amato; Lilyana Amezcua; Brenda Banwell; Amit Bar-Or; Frederik Barkhof; Helmut Butzkueven; Olga Ciccarelli; Jeremy Chataway; Jeffrey A Cohen; Giancarlo Comi; Jorge Correale; Florian Deisenhammer; Massimo Filippi; Julie Fiol; Mark S Freedman; Kazuo Fujihara; Cristina Granziera; Ari J Green; Hans-Peter Hartung; Kerstin Hellwig; Ludwig Kappos; Dorlan Kimbrough; Joep Killestein; Fred Lublin; Romain Marignier; Ruth Ann Marrie; Aaron Miller; Susana Otero-Romero; Daniel Ontaneda; Sudarshini Ramanathan; Daniel Reich; Maria A Rocca; Àlex Rovira; Shiv Saidha; Amber Salter; Jaume Sastre-Garriga; Deanna Saylor; Andrew J Solomon; Maria Pia Sormani; Bruno Stankoff; Mar Tintore; Helen Tremlett; Anneke Van der Walt; Shanthi Viswanathan; Heinz Wiendl; Brigitte Wildemann; Bassem Yamout; Paola Zaratin; Peter A Calabresi; Timothy Coetzee; Alan J Thompson
Brain atrophy and associations with long-term disability and cognitive function in participants with relapsing multiple sclerosis treated with ozanimod: Results from phase 3 and open-label extension trials

奥扎尼妥单抗治疗复发型多发性硬化患者的脑萎缩及其与长期残疾和认知功能的关系：来自III期和开放标签扩展试验的结果

Multiple Sclerosis Journal
IF5
2025-07-230
PRE
Jeffrey A Cohen; Douglas L Arnold; John DeLuca; Hans-Peter Hartung; Ludwig Kappos; Giancarlo Comi; Krzysztof Selmaj; Lawrence Steinman; Amit Bar-Or; Xavier Montalban; Eva K Havrdová; James K Sheffield; Chahin Pachai; Chun-Yen Cheng; Jon V Riolo; Bruce AC Cree
Five-Year Safety and Efficacy Outcomes with Ofatumumab in Patients with Relapsing Multiple Sclerosis

奥法木单抗在复发型多发性硬化患者中的五年安全性和有效性结局

Neurology and Therapy
IF4.8
2025-07-130
OAAI
Stephen L. Hauser; Jeffrey A. Cohen; Jérôme de Sèze; Sven G. Meuth; Paul S. Giacomini; Jin Nakahara; Celia Oreja-Guevara; Derrick Robertson; Sibyl Wray; Alit Bhatt; Xixi Hu; Jing Xi; Rebecca Piccolo; Valentine Jehl; Roseanne Sullivan; Ibolya Boer; Heinz Wiendl; Ludwig Kappos

研究方向

暂未获取到该数据
D
Daniel Ontaneda
H 指数:40论文数:300被引数:5,925
R
Ruth Ann Marrie
H 指数:94论文数:728被引数:3.9万
A
Amit Bar‐Or
H 指数:108论文数:768被引数:4.8万
B
Bruce Cree
H 指数:82论文数:499被引数:3.0万
S
Stephen C. Reingold
H 指数:47论文数:88被引数:4.5万
G
Gary Cutter
H 指数:120论文数:1,148被引数:5.8万
L
Ludwig Kappos
H 指数:137论文数:1,341被引数:10.2万
D
Devon Conway
H 指数:19论文数:112被引数:1,422
X
Xavier Montalbán
H 指数:126论文数:1,357被引数:8.8万
M
María Trojano
H 指数:92论文数:687被引数:3.6万